Amoeba Aktie
0,82EUR | -0,03EUR | -3,07% |
WKN DE: A14WL9 / ISIN: FR0011051598
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 15 | 21 | 22 | 25 | 25 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,01 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 6 | 6 | 8 | 7 | 3 |
Summe Anlagevermögen | 8 | 7 | 6 | 5 | 4 |
Summe Aktiva | 14 | 13 | 15 | 12 | 6 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 9 | 9 | 12 | 2 | 5 |
Summe Fremdkapital | 10 | 11 | 14 | 4 | 10 |
Summe Eigenkapital | 4 | 2 | 0 | 8 | -4 |
Summe Passiva | 14 | 13 | 15 | 12 | 6 |
Adresse
38, avenue des frères Montgolfier, 69680 Lyon | |
Telefon | +33 (4) 26-69-16-00 |
Fax | +33 (4) 81-13-05-69 |
Internet | http://www.amoeba-biocide.com/fr |
Management
Benoît Villers
Chairman |
Dominique Jean Francois Marie Doucet
Managing Director |
Jean Marc Petat
Director |
Jean-Baptiste Eberst
Director-Regulatory Affairs |
Jean-luc Souche
Independent Director |
Patrice Sellès
Independent Director |
Quentin Hua
Director |
Sandrine Demaneche
Scientific Director |
Valérie Filiatre
Director, Chief Financial & Administrative Officer |
Valérie Lorentz-Poinsot
Independent Director |